SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-22-008212
Filing Date
2022-03-21
Accepted
2022-03-21 17:24:11
Documents
2
Period of Report
2022-03-21

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 1456
2 POWER OF ATTORNEY exhibit24.txt EX-24 2969
  Complete submission text file 0001062993-22-008212.txt   6057
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TOBIRA THERAPEUTICS, INC. 701 GATEWAY BOULEVARD, #200 SOUTH SAN FRANCISCO CA 94080
Business Address
Lefebvre Eric (Reporting) CIK: 0001614741 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36500 | Film No.: 22756444